Subclinical Atherosclerosis in Behçet's Disease

Samia HASSAN, Tamer GHEITA, Shada GHONEIM, Loi NASR

DOI: 10.5606/tjr.2012.016

Issue: Volume 27 - Issue 2 - June 2012
9096 5152

Behçet's Disease: The Clinical and Demographic Characteristics of 406 Patients

Merih SOYLU, Hande TAYLAN ŞEKEROĞLU, Elif ERDEM, Nihal DEMİRCAN

DOI: 10.5606/tjr.2012.017

Issue: Volume 27 - Issue 2 - June 2012
8079 5337

Association of Tumor Necrosis Factor-Alpha -308 G>A Polymorphism With Rheumatoid Arthritis in Two North Indian Cohorts

Priyanka RAINA, Kawaljit MATHAROO, Ajay KUMAR, Priyanka SARANGAL, Rubina SHARMA, AJS BHANWER

DOI: 10.5606/ArchRheumatol.2014.4499

Issue: Volume 29 - Issue 4 - December 2014
7659 4353

Arterial Stiffness and Anti-Tumor Necrosis Factor-Alpha Therapy in Ankylosing Spondylitis: Results With Long-Term Two Year-Follow-Up

Murat KARKUCAK, Erhan ÇAPKIN, Abdulkadir KİRİŞ, Mürsel ŞAHİN, Ayşegül KÜÇÜKALİ TÜRKYILMAZ, Adem KARACA, Ferhat GÖKMEN, Ahmet AYAR

DOI: 10.5606/ArchRheumatol.2014.4261

Issue: Volume 29 - Issue 4 - December 2014
6442 4486

Late Onset Prosthetic Hip Joint Infection in Two Patients of Rheumatoid Arthritis Treated With Etanercept

Hayashi SHINYA, Sakai YOSHITADA, Fujishiro TAKAAKI, Hashimoto SHINGO, Kanzaki NORIYUKI, Kuroda RYOSUKE, Kurosaka MASAHIRO

DOI: 10.5606/ArchRheumatol.2015.4528

Issue: Volume 30 - Issue 2 - June 2015
5304 4272

Acute Lymphoid Leukemia After Anti-TNF-alpha Treatment: A Case Report and Review of the Literature

Füsun GEDİZ ÖZDEMİRKIRAN, Bahriye Kadriye PAYZIN, Eyüp ÇOBAN, Korhan Barış BAYRAM, Betül KÜÇÜKZEYBEK

DOI: 10.5606/ArchRheumatol.2015.5669

Issue: Volume 30 - Issue 4 - December 2015
6690 5473

The Effect of Anti-Tumor Necrosis Factor-Alpha Treatment on Muscle Performance and Endurance in Patients With Ankylosing Spondylitis: A Prospective Follow-Up Study

Musa DEMİRKAPI, Mustafa Turgut YILDIZGÖREN, Hayal GÜLER, Ayşe Dicle TURHANOĞLU

DOI: 10.5606/ArchRheumatol.2017.6335

Issue: Volume 32 - Issue 4 - December 2017
4367 5134

The Assessment of Serum Endocan Levels in Children With Juvenile Idiopathic Arthritis

Yasin YILMAZ, Rana BERRU DURMUŞ, Başak SARAÇOĞLU, Sezgin ŞAHİN, Amra ADROVIC, Kenan BARUT, Sevda ÖZEL YILDIZ, Özgür KASAPÇOPUR, Rukiye EKER ÖMEROĞLU

DOI: 10.5606/ArchRheumatol.2018.6528

Issue: Volume 33 - Issue 2 - June 2018
3316 4225

The use of anti-interleukin-1 agents and tumor necrosis factor‐alpha inhibitors in renal transplant recipients

Veli Yazısız, Vural Taner Yılmaz, İsmail Uçar, Özgür Dandin, Bengisu Aslan, Funda Erbasan, Hüseyin Koçak, Mustafa Ender Terzioğlu

DOI: 10.46497/ArchRheumatol.2021.8500

Issue: Volume 36 - Issue 3 - September 2021
1900 1777

Evaluating various radiographic methods of shoulder joint damage in patients with rheumatoid arthritis receiving biological disease-modifying antirheumatic drugs

Kazuhito Sugimori, Isao Matsushita, Tomoatsu Kimura

DOI: 10.46497/ArchRheumatol.2021.8236

Issue: Volume 36 - Issue 3 - September 2021
1185 1391

Association of TNFAIP3 gene polymorphism (rs5029939) with susceptibility and clinical phenotype of systemic lupus erythematosus

Hala Gaballah, Reham Abd-elkhalek, Ola Hussein, Shimaa Abd El-wahab

DOI: 10.46497/ArchRheumatol.2022.8769

Issue: Volume 36 - Issue 4 - December 2021
937 1409

Association of tumor necrosis factor-alpha promoter region gene polymorphism at positions -308G/A, -857C/T, and -863C/A with etanercept response in Iraqi rheumatoid arthritis patients

Samer Mohammed, Munaf Zalzala, Faiq Gorial

DOI: 10.46497/ArchRheumatol.2022.9272

Issue: Volume 37 - Issue 4 - December 2022
1014 846